SLC31A1 and lung carcinoma: Recently, a more comprehensive study based on eight datasets containing 2149 patients from nine countries, Sun et al. [8] reported that high hCtr1 expression is associated with favorable treatment outcomes in ovarian and lung cancer patients who underwent Pt-based chemotherapy.